Most recent
-
4 Sep 2014:
Guardian Australia: New agreement will permit plants to be grown across the country with Victoria the first state to start planting lucrative crop
-
4 Sep 2014: Priya Elan: The only problem with Dr Sally Marlow’s eye-opening and shocking investigation is that it should have been the first in a series rather than a one-off
-
Guardian Professional,
1 Sep 2014:
Nathan Sigworth, who set up a business fighting fake medicines in India, shares insights from his seven years of experience in India
-
31 Aug 2014: The bid from Pfizer, now active again, has caused widespread anger. But another takeover 10 years ago was a different story, writes Julia Kollewe
-
29 Aug 2014: Animals used in study all recovered as scientists say human trials should start immediately to combat west African epidemic
-
28 Aug 2014:
Clinical safety trials begin in US next week, after approval from the FDA; volunteer testing in UK and Africa from September
-
26 Aug 2014:
Royal Free hospital in Hampstead says next few days are critical for 29-year-old nurse who contracted virus in Sierra Leone
-
25 Aug 2014: Multibillion-dollar consolidation of global pharmaceutical sector continues with another blockbuster
-
23 Aug 2014:
We are in a pharmaceutical ice age. But new computer modelling and bioengineering techniques could revitalise the industry, reports Mark Piesing
-
Guardian Professional, 20 Aug 2014: National Insitute of Clinical Excellence decisions have sparked debate over funding the spiralling cost of medication, writes Andrew Apps
-
19 Aug 2014: Doctors giving out antibacterial medication, even when unnecessary, to satisfy patients or cover uncertain diagnosis
-
11 Aug 2014:
Editorial: The cancer drugs fund has become a way of escaping the constraints carefully established by Nice
-
Video
(2min 34sec),
8 Aug 2014:
The National Institute for Health and Care Excellence is too expensive for use on the NHS but Roche says it has already been picked up elsewhere
-
8 Aug 2014: Peter Humphrey and Yu Yingzeng are accused of illegally getting information on Chinese citizens
-
8 Aug 2014:
As Nice rejects breast cancer drug Kadcyla over cost, how Swiss firm has benefited from fund it played key role in establishing
1-15 of 1047 for Pharmaceuticals industry
;